Apurv Soni, MD, PhD, David McManus, MD, ScM, John Broach, MD
Rapid antigen tests’ performance is questioned with different variants and concerns about delay in diagnosis or antigen rebound are raised. Additionally, currently, we primarily rely on swab-based testing for the detection of SARS-CoV-2 infection.
STOP COVID-19 study aims to understand how antigen tests perform in comparison to PCR tests for the detection of the SARS-CoV-2 virus after the onset of symptoms. Further, we are exploring the utility of symptomology, wearable sensor data, and other multimodal inputs for the detection of the SARS-CoV-2 virus after the onset of symptoms.
We leverage a siteless design to allow anyone, anywhere, at any time to contribute to this science as long as they have access to a smartphone and reside in USA. This study features the following innovations:
Bring their own device. |
Participants’ own smart devices can be paired with MyDataHelps, a mobile application platform developed by CareEvolution, LLC. |
Record symptoms using a participant-friendly diary. |
Participants can log symptoms in the MyDataHelps app and access statistics and trends regarding their symptoms and treatments using a tool called Symptom Shark. |
Perform home-based collections for PCR results. |
We obtain molecular confirmation of viruses and understand their variant type using home-based PCR collection kits from Quest Diagnostics. |
